###begin article-title 0
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene
###end article-title 0
###begin p 1
###xml 77 100 77 100 <email xmlns:xlink="http://www.w3.org/1999/xlink">racurrie@sprintmail.com</email>
To whom correspondence should be addressed. Tel/Fax: +1 410 558 7050; Email: racurrie@sprintmail.com
###end p 1
###begin p 2
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 2
###begin p 3
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1093 1098 1093 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1225 1230 1225 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 447 453 <span type="species:ncbi:10090">murine</span>
###xml 458 463 <span type="species:ncbi:9606">human</span>
The high-mobility-group A2 protein (HMGA2) plays important functional roles in transcriptional regulation, DNA replication and chromatin structure. In this study, the effect of histone deacetylase inhibition on the transcriptional activity of the Hmga2 gene was investigated in vivo both at the endogenous gene level and in a variety of cell lines using transiently transfected promoter constructs. Trichostatin A (TSA) repressed both transfected murine and human Hmga2 promoter constructs 3-8-fold in NIH3T3, F9 and HeLa cells. Steady-state Hmga2 mRNA levels in NIH3T3 cells decreased 4-5-fold following TSA treatment, while pre- treatment of NIH3T3 cells with the transcriptional inhibitor, actinomycin D, completely blocked TSA mediated repression of the Hmga2 gene. Cross-linked chromatin immunoprecipitation (X-ChIP) analysis revealed a 5-6-fold decrease in endogenous Hmga2 promoter bound Sp1 and Sp3 proteins following TSA treatment in parallel with observed loss of acetylated histone H3 and H4. In addition, the poly-pyrimidine-tract-binding protein (PTB) was observed to bind to the Hmga2 promoter in both TSA treated and untreated NIH3T3 cells. Together, these results suggest TSA treatment leads to a decrease in Hmga2 gene transcription, and a significant decrease in promoter bound Sp1, Sp3 and acetylated histones H3 and H4.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c1">1</xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c3">3</xref>
###xml 463 464 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c4">4</xref>
###xml 753 754 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c5">5</xref>
###xml 755 756 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c7">7</xref>
The high-mobility-group (HMG) non-histone chromosomal proteins HMGA1a, A1b and A2 proteins comprise a subgroup of HMG chromatin accessory factors, often referred to as architectural proteins (1-3). These proteins are abundant low molecular mass nuclear proteins of approximately100 amino acids which each possess three copies of a nine amino acid motif (AT-hook) that interacts with the minor groove of many AT-rich promoter and enhancer DNA regulatory elements (4). These HMG proteins possess no intrinsic transcriptional activity, but function to orchestrate the assembly of nucleoprotein structures involved in gene transcription, replication and overall chromatin structure through a complex network of protein-DNA and protein-protein interactions (5-7).
###end p 5
###begin p 6
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c8">8</xref>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c9">9</xref>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c10">10</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c12">12</xref>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c13">13</xref>
###xml 77 83 <span type="species:ncbi:10090">murine</span>
###xml 273 279 <span type="species:ncbi:10090">murine</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 506 511 <span type="species:ncbi:10090">mouse</span>
###xml 605 616 <span type="species:ncbi:10105">pygmy mouse</span>
Hmga2 mRNA and protein is detected at high levels during the early stages of murine embryonic development (i.e. 10-14 d.p.c.), but not at 15 d.p.c., or in newborn tissues, as expression decreases rapidly with the beginning of organogenesis and becomes extinguished in both murine and human adult somatic tissues (8,9). Hmga2 becomes re-expressed, however, in many transformed cells and in experimental tumors, and is thought to contribute to the overall transformation process (10-12). A role for HMGA2 in mouse development is underscored by the finding that inactivation of the Hmga2 gene results in the pygmy mouse phenotype, which exhibits growth retardation, and a significant reduction of overall body adipose tissue (13).
###end p 6
###begin p 7
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c14">14</xref>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 393 395 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 393 395 393 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ob</italic></sup>
###xml 399 401 399 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 399 401 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ob</italic></sup>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c15">15</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">Mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 788 793 <span type="species:ncbi:10090">mouse</span>
Obesity-induced conditions in normal mice have been shown to increase adipocyte number due to an expansion of pre-adipocyte cells, and this results in measurable Hmga2 mRNA expression in mature adipocyte tissues under these conditions (14). Mice with a partial or complete deficiency of Hmga2 expression have been shown to resist diet-induced obesity, while disruption of the Hmga2 gene in Lepob/Lepob mice results in a reduction in obesity observed in leptin deficient ob/ob mice. Recently, the testes of Hmga2 null mice have been observed to contain few spermatids, completely lack mature spermatozoa and are not fertile at the homozygous state (15). Together, these results suggest HMGA2 plays an important role in normal embryonic development, pre-adipocyte cell proliferation and in mouse spermatogenesis.
###end p 7
###begin p 8
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c16">16</xref>
###xml 445 452 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 454 456 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 457 459 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 511 516 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 14 19 <span type="species:ncbi:9606">human</span>
The mouse and human Hmga2 proximal promoter DNA regions are highly conserved (16). These promoters contain no consensus TATA-box, but possess DNA-binding sites for the Sp1, Sp3, CTF/NF1 transcription factors as measured using mobility-shift and footprinting assays. In addition to these elements, an approximately60 bp polypyrimidine/polypurine (ppyr/ppur) region consisting of TCC repeats has been identified as an important functional element in vivo (17-19). The molecular events which serve to activate the Hmga2 gene transcription during normal embryonic development, and to repress expression in adult tissues are not well understood, nor have any distant enhancer elements been identified which may be involved in its developmental and tissue-specific transcriptional regulation.
###end p 8
###begin p 9
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 318 325 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 668 674 <span type="species:ncbi:10090">murine</span>
In this study, we have utilized the histone deacetylase (HDAC) inhibitor, trichostatin A (TSA), to investigate the responsiveness of Hmga2 promoter constructs, and the endogenous Hmga2 gene, to changes in acetylation/deacetylation state, and to identify transcriptional regulatory proteins bound to the Hmga2 promoter in vivo. TSA treatment was found to reduce both transient Hmga2 promoter activity in NIH3T3, F9 and HeLa cells, and to significantly reduce the steady-state level of endogenous Hmga2 mRNA levels in NIH3T3 cells. Cross-linked chromatin immunoprecipitation (X-ChIP) analysis revealed poly-pyrimidine-tract-binding protein (PTB) occupancy levels on the murine Hmga2 promoter do not change significantly in response to TSA, whereas, the levels of Sp1, Sp3 and acetylated H3 and H4 levels on the Hmga2 promoter, decrease significantly following TSA treatment.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Cell culture
###end title 11
###begin p 12
###xml 233 234 227 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 127 133 <span type="species:ncbi:9913">bovine</span>
NIH3T3, F9 and HeLa cells were obtained from the ATCC (Manassas, VA) and maintained in DMEM medium supplemented with 10% fetal bovine serum (FBS) (Paragon Bioservices, Baltimore, MD) in a humidified incubator at 37degreesC with 5% CO2. TSA and actinomycin D (Act-D) were obtained from Calbiochem (San Diego, CA).
###end p 12
###begin title 13
Reporter constructs
###end title 13
###begin p 14
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c20">20</xref>
###xml 183 189 <span type="species:ncbi:10090">murine</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
All plasmids were constructed by standard recombinant DNA techniques (20). DNA oligomers were synthesized by Invitrogen. Polymerase chain reactions (PCRs) were performed using normal murine or human genomic DNA (Promega), and the following specific promoter primer sets: mHMGA2, (5' primer) 5'-GGGTCGCGAGGAATTCTTTC CCCGCCTAA-3' and (3' primer) 5'-GGGACGCGTGCC GCTACCACTGCCTCTAC-3'; mHMGA2 5' deletion, (5' primer) 5'-GGGTCGCGAACCTCCGCCACCCACTGCCC-3' and (3' primer) 5'-GGGACGCGTCGCTGCAGCCG CTCGGCCTC-3'; mHMGA2 3' deletion, (5' primer) 5'-GGGTCGCGAGGAATTCTTTCCCCGCCTAA-3' and (3' primer) 5'-GCTTAGGCTGCCGCCGCTG-3'; hHMGA2, (5' primer) 5'-GGGTCGCGAGGAATTCTTTCCCCGCCTAA-3' and (3' primer) 5'-GCCTCCCGCCGCCGCTACCG-3'; hHMGA1, (5' primer) 5'-GGGTCGCGAGGGCCCACAC GCCCTGGAAG-3' and (3' primer) 5'-GGGACGCGTGC TGGTAGCAAATGCGGATC-3'; hH2B, (5' primer) 5'-CAATAGTAGTGCGTCTTCTG-3' and (3' primer) 5'-AGCACTGTGTAGCTATAAAGC-3'.
###end p 14
###begin p 15
###xml 186 189 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 779 784 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 826 828 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 772 778 <span type="species:ncbi:10090">murine</span>
###xml 862 868 <span type="species:ncbi:10090">murine</span>
PCRs were performed for 30 cycles: 94degreesC for 1 min, 92degreesC for 30 s, 60degreesC for 30 s, 72degreesC for 1 min, followed by a final extension step at 72degreesC for 5 min using Taq polymerase (Qiagen). PCR products were gel-purified and ligated into the pCRII TA vector (Invitrogen). Promoter fragments were excised from pCRII by XhoI/HindIII digestion, and directionally cloned into the pGL3 Basic Luciferase reporter vector (Promega). The hH2B promoter was excised from pCRII with KpnI/XhoI, and cloned into these sites in pGL3 to create pGL3-hH2B. The pRL-TK vector (Promega) was digested with BglII/HindIII, and the 760 bp herpes simplex virus thymidine kinase (HSVTK) promoter was cloned into the corresponding sites in pGL3 to create pGL3-HSVTK. The 102 bp murine Hmga2 ppyr/ppur region (ppyr) (-109 to -8 bp) (17) was obtained from PCR of normal murine genomic DNA as described above using the following primers: (5' primer) 5'-GGGTCGCGAACCTCCGCCACCCACTGCCC-3' and (3' primer) 5'-GGACGTCAGCGGCTGCCAA-3', and cloned into the pCRII TA vector to create pCRII-ppyr. The KpnI/XhoI fragment derived from pCRII-ppyr was cloned into the corresponding sites in pGL3-HSVTK to create pGL3-ppyr-HSVTK. pGL3-H2B was digested with BamHI/HindIII, and the promoter fragment cloned into the BglII/HindIII sites in pGL3-ppyr-HSVTK, following gel-purification and removal of the HSVTK promoter, to create pGL3-ppyr-H2B. Promoter constructs were verified by DNA sequence analysis performed by Commonwealth Biotechnologies, Inc. (CBI; Richmond, VA) using an ABI Prism DNA sequencer.
###end p 15
###begin p 16
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c8">8</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c16">16</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c18">18</xref>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c21">21</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c22">22</xref>
###xml 707 723 707 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 45 51 <span type="species:ncbi:10090">murine</span>
###xml 325 330 <span type="species:ncbi:9606">Human</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 419 424 <span type="species:ncbi:9606">human</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
###xml 511 516 <span type="species:ncbi:9606">Human</span>
###xml 551 556 <span type="species:ncbi:9606">human</span>
###xml 707 723 <span type="species:ncbi:562">Escherichia coli</span>
Murine HMGA2 (mHMGA2) contains 480 bp of the murine Hmga2 promoter (8,16,17) from -298 to +182 bp (17), the mHMGA2 5' deletion contains 274 bp of the proximal Hmga2 promoter from -115 to +158 bp inclusive of the TCC-rich ppyr/ppur region (17). The mHMGA2 3'deletion contains 325 bp of the Hmga2 promoter from -298 to +27 bp. Human HMGA2 (hHMGA2) contains 476 bp from -480 to -4 bp of the human Hmga2 promoter (18), and human HMGA1 (hHMGA1) contains 700 bp from -347 to +352 bp of the human Hmga1 promoter (21). Human H2B (hH2B) contains 200 bp of the human histone H2B promoter from -156 to +43 bp (22). Promoters are numbered according to their respective citations. Plasmid DNAs were transformed into the Escherichia coli strain, Top 10 (Invitrogen), and plasmid DNA was purified using Qiagen tip-100 columns (Qiagen) as described by the manufacturer.
###end p 16
###begin title 17
Transient transfections and luciferase assays
###end title 17
###begin p 18
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
NIH3T3 and HeLa cells were seeded in 12-well plates at 1 x 105 cells per well, and F9 at 2.5 x 105 per well. Prior to transfection, the cells were rinsed with serum-free DMEM, then cultured in 0.4 ml of serum-free DMEM. DNA constructs were incubated with Plus reagent (Invitrogen) in sterile 1x PBS (NIH3T3 and F9) or Opti-MEM (Invitrogen) (HeLa) for 15 min at room temperature. Lipofectamine (Invitrogen) (NIH3T3 and F9) or Lipofectin (Invitrogen) (HeLa cells, after 30 min incubation at room temperature in Opti-MEM) was then added, and the DNA mixture was incubated at room temperature for an additional 15 min. The DNA mixture was added to the cells, and incubated at 37degreesC for 3 h (NIH3T3, F9) or 5 h (HeLa). One milliliter of DMEM containing 15% FBS was then added to each well and the cells were incubated overnight at 37degreesC. The transfection media was replaced with fresh DMEM/10% FBS plus 200 ng/ml TSA or an equivalent volume of DMSO, and the cells were incubated for 24 h before harvest. Cells were processed using the Dual Luciferase Reporter Assay (Promega), and luciferase (LUC) activity was measured using a TD-20/20 Luminometer (Turner Designs). The pRL-null vector (Promega) was used as an internal control to normalize for transfection efficiency. TSA values were normalized to the DMSO control with or without the ppyr/ppur element, which was set to a value of 1.00, and are expressed as the standard error of the means. Duplicate or triplicate values of each construct were averaged from two to five experiments per cell line.
###end p 18
###begin title 19
RNA isolation and semi-quantitative RT-PCR
###end title 19
###begin p 20
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">free</italic>
###xml 484 486 464 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 507 509 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c23">23</xref>
###xml 510 512 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c24">24</xref>
###xml 665 667 645 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1119 1120 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c8">8</xref>
###xml 1217 1218 1161 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c8">8</xref>
###xml 1219 1221 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c25">25</xref>
###xml 1195 1201 <span type="species:ncbi:10090">murine</span>
Total RNA was extracted using RNAqueous (Ambion, Austin, TX) according to the manufacturer. RNA was quantified spectrophotometrically after treatment with DNA-free (Ambion). Extracted RNAs were additionally checked by analyzing aliquots on a 1% native agarose gel stained with ethidium bromide. RT-PCRs were generally performed with approximately1 microg of RNA in one-step RT-PCRs according to the manufacturer (Qiagen). Semi-quantitative RT-PCR analyses were performed using [alpha-32P]dCTP as described (23,24). Briefly, gene-specific PCRs were first titrated to determine linear ranges for product accumulation, then a fixed cycle number was used in subsequent 32P RT-PCRs. Negative controls were included that omitted the reverse transcription step to verify that PCR products were RNA dependent. Typical RT-PCRs were performed at 50degreesC for 30 min, 95degreesC for 15 min, 94degreesC for 30 s, 60degreesC for 30 s, 72degreesC for 1 min, using 32 cycles for mHMGA2 and 25 cycles for GAPDH with a final extension step at 72degreesC for 5 min. The following specific RT-PCR primer sets were used: mHMGA2 primers (8), 5'-ATGGACTCATACACAGCAGCAG-3' and 5'-AGGGAAT ATAGAGAGGAGAGAG-3'; and the murine GAPDH primers (8,25), 5'-TTAGCACCCCTGGCCAAGG-3' and 5'-CTTACTCCTTGGAGGCCATG-3'.
###end p 20
###begin p 21
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c8">8</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c25">25</xref>
RT-PCRs using mHMGA2 primers yield a 342 bp product (8) and using GAPDH primers a 540 bp PCR product (25). Amplified RT-PCR products were electrophoresed through a non-denaturing 5% polyacrylamide gel, dried and analyzed using a Molecular Dynamics Phosphoimager (Amersham-Pharmacia) and ImageQuant (Amersham-Pharmacia) software.
###end p 21
###begin title 22
Trichostatin A and actinomycin D treatment
###end title 22
###begin p 23
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Two 100 mm cell culture dishes were seeded with 2 x 106 NIH3T3 cells and allowed to grow overnight to 70% confluency. The next day, TSA was added directly to the cells to a final concentration of 200 ng/ml. An equivalent volume of vehicle (DMSO) was added to the second cell culture dish. After 24 h incubation, cells were harvested and total RNA was prepared as described for RT-PCR analysis. In Act-D experiments, cells were pretreated with 4 microM Act-D for 30 min prior to TSA addition.
###end p 23
###begin title 24
Cross-linked chromatin immunoprecipitation assay
###end title 24
###begin p 25
###xml 510 511 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 570 572 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c26">26</xref>
We determined conditions to produce sheared chromatin of average lengths between 0.5 and 1.5 kb using a Branson Sonifer with a 1.5 mm micro-tip. Four cell culture plates of 70% confluent NIH3T3 cells were treated with TSA or DMSO as described above. Chromatin was cross-linked by the addition of formaldehyde to a final concentration of 1% and incubated for 30 min at 37degreesC. Cells were washed twice with PBS containing protease inhibitor cocktail (Sigma). Washed cells were counted and approximately1 x 106 cells were resuspended in 200 microl of SDS lysis buffer (26).
###end p 25
###begin p 26
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 404 406 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c26">26</xref>
###xml 1279 1280 1209 1210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1469 1470 1389 1390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1547 1549 1467 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1609 1611 1529 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c16">16</xref>
###xml 1740 1742 1660 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c27">27</xref>
###xml 1858 1860 1778 1780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c28">28</xref>
###xml 1968 1971 1888 1891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1990 1992 1910 1912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c29">29</xref>
###xml 1706 1712 <span type="species:ncbi:10090">murine</span>
###xml 1834 1840 <span type="species:ncbi:10090">murine</span>
###xml 1956 1962 <span type="species:ncbi:10090">murine</span>
X-ChIP assays were performed essentially as described by Upstate Biotechnology (Lake Placid, NY). Each sample was sonicated using a Branson Sonifer at 30% intensity for 6 x 10 s bursts with a gap of 30 s between each burst. Cells were maintained on ice throughout. Sheared chromatin was centrifuged for 10 min at 14 000 g at 4degreesC, after which the supernatant was diluted 10-fold in dilution buffer (26). As input controls, 1% of each diluted supernatant was retained at this step. Sheared chromatin was pre-cleared for 1 h at 4degreesC with 50% Protein A Sepharose (Sigma), 20 microg of sonicated and sheared salmon sperm DNA and 50 microg of BSA. Sp1 (30 microg), Sp3 (10 microg), PTB (30 and 50 microg) antibodies (Santa Cruz) and acetylated histone H3 (5 microg) and acetylated histone H4 (5 microg) antibodies (Upstate Biotechnologies) were added to pre-cleared supernatant, and immunoprecipitates were allowed to form overnight at 4degreesC with end-over-end rocking. Immune complexes were incubated for 1 h at 4degreesC with 60 microl of Protein A Sepharose beads and 4 microg of sonicated and sheared salmon sperm DNA, then centrifuged gently for 5 min at 4degreesC. Beads were washed four times for 5 min, then eluted twice in 250 microl of fresh 1% SDS, 0.1 M NaHCO3. Samples were heated at 65degreesC for 4 h to reverse cross-links, then the DNA samples were phenol/chloroform extracted before ethanol precipitation. DNA was resuspended in 50 microl of H2O. X-ChIP samples including input controls were assayed by semi-quantitative 32P-PCR using the following primers: mHMGA2 promoter primers (16) to amplify a product of 477 bp, 5'-GGA ATTCTTTCCCCGCCTAA-3' and 5'-GCCGCTACCACTG CCTCTAC-3'; murine H-rev107 promoter primers (27) to amplify a product of 280 bp, 5'-GAGGAGTGTG TATAGGCTG-3' and 5'-CTTTGCTTGGGTCCCAGAA-3'; murine PO gene primers (28) to amplify a product of 552 bp, 5'-GTGATGCCCAGGGAAGACAGG-3' and 5'-GTCTCCA GTCTTTATCAGCTG-3'; murine c-Ki-ras promoter primers (29) to amplify a product of 500 bp, 5'-GTCGGGG TCCGCGTTGGCCG-3' and 5'-GAGCCGGCTTCATTC AGCGCCG-3'.
###end p 26
###begin p 27
###xml 216 218 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
PCR conditions included one cycle of 3 min at 94degreesC; then 30 s at 94degreesC, 30 s at 60degreesC, 40 s at 72degreesC, for 30, 32, 36, 38 or 44 cycles, with a final extension step at 72degreesC for 5 min. X-ChIP 32P-PCR products were analyzed by phosphoimager analysis as described above for semi-quantitative RT-PCR.
###end p 27
###begin title 28
RESULTS
###end title 28
###begin title 29
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
TSA represses Hmga2 promoter activity
###end title 29
###begin p 30
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f1">1</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f2">2</xref>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f2">2</xref>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f2">2</xref>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 729 734 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 776 777 776 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f2">2</xref>
###xml 809 810 809 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f2">2</xref>
###xml 897 902 885 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 930 931 918 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f2">2</xref>
###xml 1025 1026 1013 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f2">2</xref>
###xml 1048 1053 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga1</italic>
###xml 1180 1185 1168 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1196 1198 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c21">21</xref>
###xml 1199 1201 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c22">22</xref>
###xml 1331 1332 1319 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f2">2</xref>
###xml 1346 1348 1334 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c30">30</xref>
###xml 1396 1401 1384 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 279 285 <span type="species:ncbi:10090">murine</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 439 445 <span type="species:ncbi:10090">murine</span>
###xml 723 728 <span type="species:ncbi:9606">human</span>
###xml 891 896 <span type="species:ncbi:9606">human</span>
The murine and human Hmga2 promoters, and several control promoters were cloned into the pGL3 Basic LUC vector (Fig. 1), and tested in transient transfection assays to assess the effect of TSA on promoter activity in NIH3T3, F9 and HeLa cell lines (Fig. 2). Both the full-length murine and human Hmga2 promoters were down-regulated from 50 to 88%, in response to TSA in these cell lines (Fig. 2A-C, lanes 1 and 4). Of particular note, the murine Hmga2 promoter deletions which retain the TCC-rich ppyr/ppur region (17,19) were also down-regulated by TSA (Fig. 2A-C, lanes 2 and 3), suggesting Hmga2 promoter TSA responsiveness may require this ppyr/ppur region. TSA had no, or little, effect on the activity of the control human Hmga1 promoter construct in NIH3T3 cells (Fig. 2A, lane 5) and HeLa cells (Fig. 2C, lane 5), respectively, and resulted in an approximately2-fold increase in the human Hmga1 promoter in F9 cells (Fig. 2B, lane 5). TSA increased histone H2B promoter LUC activity in both NIH3T3 and F9 cells (Fig. 2A and B, lane 6). The Hmga1, and H2B promoters serve as controls in these TSA experiments, as these promoters share no known common DNA elements with the Hmga2 promoter (21,22). The additional positive control promoter, HSVTK, exhibited a 5-27-fold induction in promoter activity in response to TSA (Fig. 2A-C, lane 7) (30). These results suggest TSA down-regulates the Hmga2 promoter at the transcriptional level.
###end p 30
###begin p 31
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f3">3</xref>
###xml 578 579 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f3">3</xref>
###xml 846 847 822 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f3">3</xref>
###xml 1099 1100 1051 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f3">3</xref>
###xml 1137 1142 1089 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1521 1526 1473 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 36 42 <span type="species:ncbi:10090">murine</span>
###xml 1130 1136 <span type="species:ncbi:10090">murine</span>
To examine the possible role of the murine Hmga2 ppyr/ppur element in TSA mediated transcriptional repression, the ppyr/ppur element was transferred to a 5' position in the HSVTK and H2B promoters, and tested in NIH3T3 and F9 cells (Fig. 3). The ppyr/ppur element was observed to stimulate the HSVTK promoter approximately3-fold in both NIH3T3 and F9 cells, and stimulate the H2B promoter approximately5-6-fold in NIH3T3 cells in the absence of TSA. However, the ppyr/ppur element only slightly increased the activity of the H2B promoter in F9 cells in the absence of TSA (Fig. 3B). As observed previously, both the HSVTK and H2B promoters were activated by TSA in NIH3T3 and F9 cells. Transfer of the ppyr/ppur element to the HSVTK and H2B promoters, however, effectively blocked TSA mediated activation of these promoters in NIH3T3 cells (Fig. 3A). Similarly, in F9 cells, the ppyr/ppur element repressed the HSVTK promoter response 68% (approximately3-fold) in TSA treated cells, however, in F9 cells the ppyr/ppur H2B promoter activity was increased approximately2-fold in response to TSA (Fig. 3B). These results suggest the murine Hmga2 ppyr/ppur element is capable of transferring TSA mediated repression to heterologous promoters, however, cell-type and promoter-specific differences were observed in one case. In F9 cells, and only in the case of the H2B promoter, a small increase in promoter activity was observed with the ppyr element following TSA treatment. These results suggest TSA mediated repression of Hmga2, and heterologous promoters containing the ppyr element, may depend on additional cell-specific factors and overall promoter-specific architecture.
###end p 31
###begin title 32
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
TSA reduces steady-state Hmga2 mRNA levels at the transcriptional level
###end title 32
###begin p 33
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c31">31</xref>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f4">4</xref>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 631 636 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 748 753 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 847 849 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c27">27</xref>
###xml 850 852 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c32">32</xref>
###xml 903 905 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c27">27</xref>
###xml 906 908 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c33">33</xref>
###xml 1010 1015 998 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1075 1076 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f4">4</xref>
###xml 1130 1135 1118 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1163 1170 1151 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
NIH3T3 cells are known to express high steady-state levels of Hmga2 mRNA (31). To determine if TSA is capable of regulating endogenous Hmga2 gene expression, Hmga2 mRNA levels in NIH3T3 cells were quantitated by RT-PCR analysis following TSA or DMSO treatment (Fig. 4). From two independent experiments we observed a 4.7-fold reduction in steady-state Hmga2 mRNA levels in TSA treated cells, suggesting TSA may affect the Hmga2 gene transcription rate, Hmga2 mRNA stability, or both. In further support of RT-PCR analysis of Hmga2 mRNA levels, northern blot analysis also revealed a significant decrease in the approximately3.7 kb Hmga2 mRNA species in TSA treated NIH3T3 cells (data not shown). To evaluate possible effects of TSA at the level of Hmga2 gene transcription, NIH3T3 cells were pre-treated with the transcriptional inhibitor, Act-D (27,32), 30 min prior to addition of either TSA or DMSO (27,33). From two independent experiments, RT-PCR analysis showed repressive effects of TSA on steady-state Hmga2 mRNA levels were blocked by pre-treatment with Act-D (Fig. 4). These results suggest TSA repression occurs at the Hmga2 gene transcriptional level in vivo.
###end p 33
###begin title 34
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 73 79 <span type="species:ncbi:10090">murine</span>
TSA reduces occupancy of acetylated histones H3 and H4 on the endogenous murine Hmga2 promoter
###end title 34
###begin p 35
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c34">34</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c36">36</xref>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f5">5</xref>
###xml 697 699 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c28">28</xref>
###xml 870 871 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f5">5</xref>
###xml 998 1003 986 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1072 1079 1060 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1109 1114 1097 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1303 1308 1291 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1324 1325 1312 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f5">5</xref>
###xml 635 641 <span type="species:ncbi:10090">murine</span>
Histone acetylation is thought to be a crucial event in the remodeling of chromatin to allow greater accessibility of transcription factors to their DNA-binding sites resulting in an increased level of gene transcription. Localized acetylation of histones H3 and H4 in gene promoters have frequently been observed to be associated with active gene expression (34-36). The effect of TSA was further analyzed in the context of Hmga2 promoter localized histone H3 and H4 acetylation. Antibodies that specifically immunoprecipitate acetylated histones H3 and H4 were used in the X-ChIP assay (Fig. 5). An approximately500 bp region of the murine PO gene spanning the protein translational start site (28) was PCR amplified from input and immunoprecipitated acetylated H3 and H4 antibody X-ChIP samples at 38 and 44 PCR cycles, respectively, to verify sample integrity (Fig. 5C and D). X-ChIP analysis of DMSO treated cells revealed the presence of acetylated H3 and H4 histones (30 PCR cycles), on the Hmga2 promoter, commonly found associated with actively transcribed genes in vivo. Consistent with TSA induced Hmga2 gene transcriptional repression, X-ChIP analysis of TSA treated NIH3T3 cells showed a reduction of acetylated H3 and H4 histones (30 PCR cycles) by 2.2- and 2.5-fold, respectively, on the Hmga2 promoter (Fig. 5A and B).
###end p 35
###begin title 36
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 42 48 <span type="species:ncbi:10090">murine</span>
Sp1 and Sp3 are present on the endogenous murine Hmga2 promoter
###end title 36
###begin p 37
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c18">18</xref>
###xml 161 169 161 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 269 292 269 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophlia melanogaster</italic>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f6">6</xref>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f6">6</xref>
###xml 1047 1052 1047 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1168 1169 1168 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f6">6</xref>
###xml 1250 1255 1250 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1265 1272 1265 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1444 1446 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c27">27</xref>
###xml 1572 1573 1572 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f6">6</xref>
###xml 116 122 <span type="species:ncbi:10090">murine</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 672 678 <span type="species:ncbi:10090">murine</span>
###xml 1243 1249 <span type="species:ncbi:10090">murine</span>
###xml 1379 1385 <span type="species:ncbi:10090">murine</span>
###xml 1541 1547 <span type="species:ncbi:10090">murine</span>
The ubiquitous transcription factors Sp1 and Sp3 have been implicated as positive transcriptional activators of the murine (17) and human Hmga2 genes (18), from in vitro DNA-binding assays, in vivo reporter assays and from in vivo transfection experiments performed in Drosophlia melanogaster SL-2 cells using Sp1 and Sp3 expression vectors. To determine if Sp1 and Sp3 proteins are indeed present on the endogenous Hmga2 promoter during active transcription in vivo, and to evaluate their potential status following TSA treatment, we performed X-ChIP analysis using NIH3T3 cells (Fig. 6). Using this approach, both Sp1 and Sp3 proteins were observed to be present on the murine Hmga2 promoter in both TSA treated and untreated cells (Fig. 6A and B, respectively). By normalizing each immunoprecipitation (IP) reaction to the corresponding input control we determined that the relative abundance of both Sp1 and Sp3 decreased 5-6-fold in TSA treated NIH3T3 cells as compared to control. However, 38 cycles were required to detect Sp3 bound to the Hmga2 promoter, whereas Sp1 was detected using 32 cycles in the X-ChIP assay in both control and TSA treated cells (Fig. 6C). These results suggest that both Sp1 and Sp3 proteins are bound to the murine Hmga2 promoter in vivo, and are both significantly reduced following TSA treatment. Both Sp1 and Sp3 have been identified on the murine H-rev107 promoter in NIH3T3 cells using the X-ChIP assay (27). As a positive control, we assayed our Sp1 and Sp3 X-ChIP samples, and likewise detected the murine H-rev107 promoter (Fig. 6D). Sp1 and Sp3 were not detected using 32 cycles in X-ChIP PCRs of the H-rev107 promoter, but required 36 cycles to detect.
###end p 37
###begin title 38
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 20 26 <span type="species:ncbi:10090">murine</span>
PTB is bound to the murine Hmga2 and c-Ki-ras promoters in vivo
###end title 38
###begin p 39
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c33">33</xref>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c37">37</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c38">38</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c33">33</xref>
###xml 330 335 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 397 399 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 418 421 406 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 466 468 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 469 471 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c29">29</xref>
###xml 551 553 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c28">28</xref>
###xml 605 610 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1091 1092 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f7">7</xref>
###xml 1149 1154 1125 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1164 1171 1140 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1413 1415 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c28">28</xref>
###xml 1679 1686 1647 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1693 1694 1661 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f7">7</xref>
###xml 1714 1717 1682 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1791 1796 1759 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1811 1819 1779 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1883 1885 1851 1853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 1886 1888 1854 1856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c29">29</xref>
###xml 2027 2030 1991 1994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 2040 2047 2004 2011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2128 2131 2088 2091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 2173 2174 2133 2134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f7">7</xref>
###xml 2231 2234 2191 2194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 2244 2251 2204 2211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2439 2446 2399 2406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 406 412 <span type="species:ncbi:10090">murine</span>
###xml 486 492 <span type="species:ncbi:10090">murine</span>
###xml 1142 1148 <span type="species:ncbi:10090">murine</span>
###xml 1351 1357 <span type="species:ncbi:10090">murine</span>
###xml 1702 1708 <span type="species:ncbi:10090">murine</span>
###xml 2015 2021 <span type="species:ncbi:10090">murine</span>
PTB is known to play a role in pre-mRNA splicing and mRNA translation (33,37,38), and is thought to participate in the control of gene transcription by binding to single-stand ppyr/ppur DNA elements in regulatory control regions (19,33). An approximately60 bp ppyr/ppur region consisting of TCC repeats has been identified in the Hmga2 promoter, and shown to function in promoter reporter assays (19). The murine c-Ki-ras promoter also possesses a ppyr/ppur region (19,29), whereas the murine acidic ribosomal phosphoprotein (PO; also known as 36B4) (28) gene lacks an identifiable ppyr/ppur element. The Hmga2 promoter together with these additional promoters were assayed for PTB binding using the X-ChIP assay, as additional controls were considered important, since to our knowledge, PTB has not been previously identified on any endogenous gene using the X-ChIP assay. To characterize the alpha-PTB reagent, two concentrations of alpha-PTB antibodies (30 and 50 microg) were tested to ensure complete IP, and both yielded identical results (data not shown). Results presented in Figure 7A demonstrate that PTB is bound to the endogenous murine Hmga2 promoter in vivo, with a 1.4-fold decrease in bound PTB in TSA treated NIH3T3 cells as compared to DMSO treated cells. To control for the specificity of the alpha-PTB X-ChIP assay a region of the murine PO gene spanning the protein translational start site (28) was PCR amplified from input X-ChIP samples at 38 PCR cycles. As expected, input samples yielded a PCR product corresponding to the PO gene, whereas alpha-PTB IP samples showed no PO product demonstrating the absence of PTB binding in this region of the PO gene in vivo (Fig. 7B). The murine c-Ki-ras promoter contains a shorter, but similar ppyr/ppur region as compared to Hmga2 promoter, and in vitro EMSA experiments demonstrate this ppyr/ppur element binds PTB (19,29). To provide a positive control for our alpha-PTB IP experiments, and to determine if PTB is actually bound to the endogenous murine c-Ki-ras promoter in vivo, we performed similar alpha-PTB X-ChIP assays using primers which span the c-Ki-ras ppyr/ppur element in this promoter (Fig. 7B). Our results suggest PTB is in fact bound to the c-Ki-ras promoter in vivo, and PTB levels decrease by a factor of 1.7-fold following TSA treatment in NIH3T3 cells. These results represent the first demonstration of PTB binding to ppyr/ppur containing promoters in vivo.
###end p 39
###begin title 40
DISCUSSION
###end title 40
###begin p 41
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c39">39</xref>
Hmga2 gene expression has been extensively characterized due to its important role in major cellular functions such as transcription, replication and control of chromatin structure. Overexpression of the Hmga2 gene is a common feature of many benign tumors of mesenchymal origin, and the role of Hmga2 in malignant tumor biology has been recently demonstrated where targeted anti-sense Hmga2 expression suppresses malignant transformation of thyroid cells by acute retroviruses (39).
###end p 41
###begin p 42
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c40">40</xref>
###xml 751 756 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c39">39</xref>
###xml 1131 1133 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c40">40</xref>
###xml 1134 1136 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c41">41</xref>
###xml 1272 1274 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c40">40</xref>
###xml 1450 1452 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c42">42</xref>
###xml 1500 1502 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c43">43</xref>
###xml 523 528 <span type="species:ncbi:9606">human</span>
###xml 951 956 <span type="species:ncbi:9606">human</span>
###xml 1507 1513 <span type="species:ncbi:10090">murine</span>
Dynamic control of protein acetylation is now widely believed to be involved in regulating gene transcription through the interplay of histone acetyltransferase (HAT) and HDAC enzymes, which modify histones, transcription factors, and their associated cofactors and accessory chromatin factors. Specific HDAC inhibitors, such as TSA, have been employed to alter the level of histone acetylation, and to assess their functional impact on transcriptional activity of specific genes. Currently, over 10 HDAC inhibitors are in human clinical trials and represent a new anti-cancer therapeutic agent due to their ability to induce cell death and cell cycle arrest in tumor cells (40). HDAC inhibitors, such as TSA, may represent novel agents that decrease Hmga2 expression, thereby suppressing malignant cell transformation as has been shown using anti-sense methodologies (39). Recent microarray analysis of TSA effects on cellular gene expression in the human colon carcinoma cell line, SW620, suggests only a limited number of mammalian genes, approximately10% of >8000 genes examined, are significantly affected by HDAC inhibition (40,41). In the majority of genes examined using standard molecular biological assays, TSA treatment leads to an increase in gene expression (40). Of the few examples where inhibition of HDAC results in repression, TSA has been shown to decrease protein and mRNA levels of both the ETS domain transcription factor PU.1 (42) and the tetraspanin cell surface antigen CD9 (43) in murine macrophage cell lines.
###end p 42
###begin p 43
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 157 164 157 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 275 281 <span type="species:ncbi:10090">murine</span>
###xml 350 356 <span type="species:ncbi:10090">murine</span>
###xml 361 366 <span type="species:ncbi:9606">human</span>
To better understand the mechanisms of Hmga2 gene regulation we have investigated the effect of HDAC inhibition on the activity of the endogenous Hmga2 gene in vivo and Hmga2 promoter constructs in transfected cells. Transient transfection assays demonstrated both human and murine Hmga2 promoters were down-regulated following TSA treatment in both murine and human cell lines. Using both RT-PCR and northern analysis we observed a significant decrease in endogenous Hmga2 steady-state mRNA levels, while pretreatment of NIH3T3 with Act-D blocked this repression. Taken together, these results suggest repression of Hmga2 gene expression occurs at the transcriptional level.
###end p 43
###begin p 44
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c34">34</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c35">35</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c36">36</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c26">26</xref>
###xml 720 725 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c42">42</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c44">44</xref>
###xml 1216 1218 1216 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c45">45</xref>
Acetylated histones have been consistently observed associated with a more open and active chromatin environment leading to the hypothesis that HAT enzymes and histone acetylation are involved in transcriptional activation while HDAC enzymes and deacetylated histones are associated with gene repression. An increase in histone acetylation in promoters associated with TSA mediated gene induction has been observed in the majority of TSA inducible genes. A number of TSA inducible genes such as manganese superoxide dismutase (34), MKP-1 (35), HMG-CoA (36) and hLHR (26) have increased acetylated histone H3 and/or H4. Our data is consistent with this model in so far as acetylated histones H3 and H4 are present at the Hmga2 promoter under conditions favoring active gene transcription, but reduced in the repressed state. An interesting example of one of the few genes that are repressed by TSA, PU.1 associated histones H3 and H4 remained acetylated, and in the case of histone H4, TSA treatment actually increased its level of acetylation on the PU.1 promoter (42). It should be noted that TSA treatment not only leads to histone acetylation, but has also been shown to acetylate other transcription factors (44,45).
###end p 44
###begin p 45
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 251 261 251 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c17">17</xref>
###xml 497 505 497 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 736 743 736 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 787 792 787 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 869 874 869 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 251 261 <span type="species:ncbi:7227">Drosophila</span>
###xml 309 315 <span type="species:ncbi:10090">murine</span>
Recent studies have implicated a role for the Sp1 and Sp3 transcription factors in Hmga2 promoter activity and shown protein binding within the highly conserved TCC-rich ppyr/ppur region at position -83 to -25 bp (17-19). Ectopic expression of Sp1 in Drosophila SL-2 cells has also been shown to activate the murine Hmga2 promoter, while Sp3 enhances Sp1 functional activity but does not activate Hmga2 expression alone (17). In addition, a member of the hnRNP family, PTB, has been shown to bind in vitro within the Hmga2 ppyr/ppur tract when a single-stranded DNA conformation exists, suggesting PTB may play a functional role in Hmga2 transcription (19). Our results demonstrate that Sp1, Sp3 and PTB are bound to the Hmga2 promoter in vivo and suggest TSA mediated repression of the Hmga2 gene involves loss of bound Sp1 and Sp3 proteins, which is dependent on the Hmga2 ppyr/ppur region.
###end p 45
###begin p 46
###xml 178 187 178 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">waf1/cip1</italic>
###xml 178 187 178 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>waf1/cip1</italic></sup>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c46">46</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c47">47</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c41">41</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c41">41</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c46">46</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c48">48</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c47">47</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c41">41</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c26">26</xref>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c27">27</xref>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c41">41</xref>
###xml 1186 1188 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c46">46</xref>
###xml 194 199 <span type="species:ncbi:9606">human</span>
###xml 541 546 <span type="species:ncbi:9606">human</span>
Sp1 and Sp3 are involved in transcriptional activation and repression of a large number of eukaryotic genes. In cases of TSA mediated activation, a number of genes, including p21waf1/cip1 (46), human telomerase reverse transcriptase (47) and manganese superoxide dismutase (41) depend on functional Sp1/Sp3 promoter sites. In general, HDAC enzymes are associated with Sp1 directly or present within these proximal promoter regions to maintain the repressed state, and dissociate following promoter activation by TSA (41,46-48). For both the human telomerase reverse transcriptase (47) and manganese superoxide dismutase (41) promoters, X-ChIP analyses show Sp1/Sp3 occupancy levels do not change with TSA mediated activation. These X-ChIP results suggest HDAC inhibition and gene activation do not involve any significant increase in promoter bound Sp1/Sp3 activator proteins, but may involve de-repression through the loss of bound HDAC enzymes. It is important to also note the levels of total nuclear extracted Sp1/Sp3 protein and its DNA-binding activity as measured using several distinct Sp1/Sp3 DNA-binding sites in these studies were unchanged following TSA treatment (26,27,41,46).
###end p 46
###begin p 47
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 97 104 97 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 218 225 218 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c26">26</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c27">27</xref>
###xml 1035 1040 1035 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1188 1193 1188 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
The X-ChIP assay provided an opportunity to identify proteins associated with the Hmga2 promoter in vivo. Our data provide the first evidence that both Sp1 and Sp3 transcription factors are bound to the Hmga2 promoter in vivo, and additionally that occupancy levels of Sp1 and Sp3 decrease significantly following TSA treatment. It is important to note, however, that the PCR cycle number was extended six cycles further to 38 cycles in order to detect and quantitate Sp3 levels. Loss of Hmga2 bound Sp1 and Sp3 proteins strongly suggests transcriptional repression is mediated through loss of these activator proteins, and to our knowledge this is the first demonstration of the loss of Sp1/Sp3 activator proteins following HDAC inhibition. It is also highly likely that the loss of Sp1/Sp3 in the presence of TSA is localized and specific to the Hmga2 promoter, as in other studies no TSA effects on total nuclear Sp1 protein abundance or DNA-binding activity have been observed (26,27). The presence of the ppyr/ppur element in the Hmga2 is known to provide a site for Sp1/Sp3 transcription factors and also for the PTB protein and may play a crucial role in overall repression of the Hmga2 promoter.
###end p 47
###begin p 48
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 394 402 394 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c19">19</xref>
###xml 524 531 524 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 592 599 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 890 893 890 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 1022 1029 1022 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1177 1184 1177 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1266 1273 1266 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1365 1370 1365 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1426 1431 1426 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1764 1769 1764 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1860 1862 1860 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c49">49</xref>
###xml 1905 1910 1905 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1965 1970 1965 1970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 2475 2477 2475 2477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c44">44</xref>
###xml 2478 2480 2478 2480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c45">45</xref>
###xml 329 335 <span type="species:ncbi:10090">murine</span>
To further elucidate possible mechanisms of TSA mediated Hmga2 repression, the X-ChIP assay was performed with NIH3T3 cells to determine if PTB is bound in vivo to the endogenous Hmga2 and c-Ki-ras promoter ppyr/ppur elements, and if PTB protein occupancy levels change following HDAC inhibition. Previous studies have shown the murine Hmga2 promoter can adopt S1 nuclease sensitive structures in vitro which are capable of binding PTB (19), however, it is not known if single-stranded regions in the ppyr/ppur region exist in vivo. Our results demonstrate PTB is bound to the Hmga2 promoter in vivo, and show no significant decrease (1.4-fold) in the level of bound PTB in TSA treated cells as compared to untreated cells. These results suggest repression of Hmga2 gene transcription is not associated with increased levels of promoter bound PTB. PTB levels decreased 1.7-fold on the c-Ki-ras promoter following TSA treatment as compared to DMSO treatment. The significance of reduced PTB levels on the c-Ki-ras promoter in vivo are not known at present. Together, these X-ChIP analyses represent the first demonstration of PTB bound to ppyr/ppur element containing promoters in vivo, and suggest single-stranded H-DNA structures do indeed exist on these promoters in vivo. Although the precise role of PTB in both transcriptional activation and repression of the Hmga2 gene is not understood, TSA mediated repression of the Hmga2 gene may involve remodeling of PTB within the ppyr/ppur element such that double-stranded Sp1/Sp3 DNA-binding sites are converted into single-stranded sites following redistribution of PTB, which effectively reduces the level of bound Sp1/Sp3. Alternatively, TSA may stimulate covalent modification of Sp1/Sp3 proteins bound to the Hmga2 promoter that prevents their DNA-binding, leading to reduction in promoter bound Sp1/Sp3 (49). It is also possible that a repressor of Hmga2 gene transcription is induced by TSA and binds in the Hmga2 promoter region displacing Sp1 and Sp3. A bound repressor may result in histone deacetylation due to the loss of Sp1/Sp3 associated HAT activity and this may lead to remodeling of nucleosomes and a closed chromatin environment. An additional possibility is that TSA mediated transcriptional repression of the Hmga2 promoter is indirect where HDAC inhibition leads to acetylation of other non-histone chromosomal proteins such as p300 or CBP in addition to histones, which activates repressor expression (44,45).
###end p 48
###begin p 49
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c50">50</xref>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg403c51">51</xref>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 798 803 798 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 875 880 875 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 965 970 965 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 1039 1044 1039 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 412 418 <span type="species:ncbi:10090">murine</span>
Current studies are directed at determining if loss of histone acetylation is a result of deacetylation or remodeling of nucleosomes following TSA treatment and if known HAT enzymes, such as p300, CBP or pCAF, possibly associated with Sp1/Sp3, or within the Hmga2 ppyr/ppur region in vivo, may be displaced during HDAC inhibition. The inability of ectopically expressed p300 or CBP proteins (50) to activate the murine Hmga2 promoter in NIH3T3 cells, however, coupled with the inability of the adenovirus E1A 12S oncoprotein (51) to repress transient Hmga2 promoter activity, suggest these HAT enzymes and E1A 12S protein may not play a role in activation/repression of Hmga2 gene transcription (P.A.Henry, M.Ferguson and R.A.Currie, unpublished results). Further X-ChIP analysis of the endogenous Hmga2 gene for the presence of HAT activities and functional analysis of the Hmga2 promoter, should provide additional new insights into the mechanism of TSA mediated Hmga2 gene repression, and identification of basic components involved in Hmga2 transcriptional control.
###end p 49
###begin title 50
Figures and Tables
###end title 50
###begin p 51
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 403 409 <span type="species:ncbi:10090">murine</span>
 Schematic representation of promoter regions cloned into the pGL3 Basic vector and tested in vivo. The 5' and 3' base pair positions of each promoter are denoted below at the left and right. The location of each promoter initiation site is denoted by a bent arrow. The TCC-rich ppyr region is denoted by a hatched box and its base pair position denoted. hH2B ppyr and HSVTK ppyr constructs contain the murine Hmga2 ppyr element. Promoter construction is described in Materials and Methods.
###end p 51
###begin p 52
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 107 108 107 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 115 116 115 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 128 129 128 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
 TSA down-regulates Hmga2 promoter activity. Promoter constructs were transiently transfected into NIH3T3 (A), F9 (B) and HeLa (C) cells. Cells were treated with TSA or DMSO for 24 h, then LUC activity was measured. The fold change in promoter activity following TSA treatment is shown normalized to the internal control, pRL-null, and to the DMSO controls, which were set to a value of 1.00. Promoter constructs are labeled above each pair of comparisons (DMSO and TSA), which are numbered at the bottom. The mean fold change values are shown below each numbered comparison.
###end p 52
###begin p 53
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 268 269 268 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 279 280 279 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 85 91 <span type="species:ncbi:10090">murine</span>
 Effect of TSA on heterologous promoters containing the Hmga2 ppyr/ppur element. The murine Hmga2 ppyr/ppur element was positioned 5' of the HSVTK and H2B promoters and compared to control promoter LUC activity following treatment with TSA or DMSO for 24 h in NIH3T3 (A) and F9 (B) cells. LUC activities were normalized to the internal control, pRL-null, and to the HSVTK and H2B promoter constructs with or without the ppyr/ppur element treated with DMSO which were set to a value of 1.00. Promoter constructs are denoted above each bar, and the mean fold change values are shown below for each construct.
###end p 53
###begin p 54
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 78 79 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 333 338 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 422 424 418 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 456 461 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 493 498 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 533 534 529 530 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 58 64 <span type="species:ncbi:10090">murine</span>
 TSA represses transcriptional activity of the endogenous murine Hmga2 gene. (A) Semi-quantitative RT-PCR was performed on RNA derived from NIH3T3 cells treated with 200 ng/ml TSA or DMSO for 24 h. In addition, NIH3T3 cells were pre-treated for 30 min with or without 4 microM Act-D (lanes 3, 4, 7, 8). RNA samples were analyzed for Hmga2 (lanes 1-4) and GAPDH mRNA levels which served as an internal control (lanes 5-8). 32P-PCR products corresponding to Hmga2 and GAPDH were quantified, and Hmga2 levels were normalized to GAPDH. (B) Quantitated results are expressed as the average fold change of two experiments relative to the DMSO controls.
###end p 54
###begin p 55
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 361 362 357 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 378 379 370 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 412 417 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 450 451 442 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 456 457 448 449 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 99 105 <span type="species:ncbi:10090">murine</span>
 TSA treatment of NIH3T3 cells results in a decreased level of acetylated histone H3 and H4 on the murine Hmga2 promoter. X-ChIP analysis was performed on NIH3T3 cells treated with 200 ng/ml TSA or DMSO for 24 h using acetylated H3 and H4 antibodies. Cross-linked and sheared genomic DNA (input) serve as positive controls, and were used to normalize alpha-H3 (A) and alpha-H4 (B) IP results. In addition to the Hmga2 promoter (A and B) the PO gene (C and D) was detected by PCR amplification from input and IP samples to serve as a control for sample integrity.
###end p 55
###begin p 56
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 162 163 162 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 174 175 174 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 302 304 302 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 477 478 477 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 623 624 623 624 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 30 36 <span type="species:ncbi:10090">murine</span>
###xml 597 603 <span type="species:ncbi:10090">murine</span>
 Sp1 and Sp3 are bound to the murine Hmga2 promoter in vivo. X-ChIP analysis was performed on NIH3T3 cells treated with 200 ng/ml TSA or DMSO for 24 h using Sp1 (A) and Sp3 (B) antibodies. Cross-linked and sheared genomic DNA (input) served as positive controls, and were used to normalize IP results. 32P-PCR bands corresponding to the Hmga2 promoter were quantified, and fold changes are expressed as a function of the X-ChIP results divided by the respective input control (C). As an additional control, input and IP samples from DMSO treated NIH3T3 cells were examined for the presence of the murine H-rev107 promoter (D).
###end p 56
###begin p 57
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 258 259 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f5">5</xref>
###xml 264 265 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg403f6">6</xref>
###xml 318 323 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hmga2</italic>
###xml 353 355 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 380 381 376 377 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 471 472 467 468 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 522 525 518 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 569 572 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras</italic>
###xml 21 27 <span type="species:ncbi:10090">murine</span>
###xml 438 444 <span type="species:ncbi:10090">murine</span>
###xml 510 516 <span type="species:ncbi:10090">murine</span>
 PTB is bound to the murine Hmga2 and c-Ki-ras promoters in both TSA treated and untreated NIH3T3 cells. NIH3T3 cells were treated with 200 ng/ml TSA or DMSO for 24 h and analyzed using the X-ChIP assay employing alpha-PTB antibodies as described in Figures 5 and 6. Input and IP chromatin samples were analyzed using Hmga2 promoter-specific primers in 32P-PCRs, then quantified (A). In addition, input and IP samples were analyzed using murine PO gene-specific primers (B), and IP samples were analyzed using murine c-Ki-ras promoter-specific primers. The PO and c-Ki-ras IP reactions serve as negative and positive controls, respectively.
###end p 57
###begin title 58
ACKNOWLEDGEMENTS
###end title 58
###begin p 59
This work was supported by research grants, NIDDK 47272 and AI44111 from the National Institutes of Health to R.A.C.
###end p 59
###begin title 60
REFERENCES
###end title 60

